A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models

A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models

Abstract Background Osteoarthritis (OA) is a common progressive joint disease in dogs and cats. The goal of OA treatment is to reduce inflammation, minimize pain, and maintain joint function. Currently, non-steroidal anti-inflammatory drugs (e.g., meloxicam) are the cornerstone of treatment for OA p...

Full description

Bibliographic Details
Main Authors: Domenico Britti, Rosalia Crupi, Daniela Impellizzeri, Enrico Gugliandolo, Roberta Fusco, Carlo Schievano, Valeria Maria Morittu, Maurizio Evangelista, Rosanna Di Paola, Salvatore Cuzzocrea
Format: Article
Language:English
Published: BMC 2017-08-01
Series:BMC Veterinary Research
Subjects:
Osteoarthritis
Disease models
Pain
Inflammation
Drug combinations
Palmitoylethanolamide
Online Access:http://link.springer.com/article/10.1186/s12917-017-1151-z

Internet

http://link.springer.com/article/10.1186/s12917-017-1151-z

Similar Items